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E-mail addresses: zhihuali2002@163.com (Z. Li), chHepatitis C Virus core protein (HCVc) plays important roles in the development of intrahepatic chol-
angiocarcinoma (ICC). MicroRNAs (miRNAs) contribute to tumor progression by interacting with
downstream target genes. However, the regulation and role of miRNAs in HCV-related intrahepatic
cholangiocarcinoma (HCV-ICC) is poorly understood. In this study, we found that miR-124 was
down-regulated in HCV-ICC and the induction of DNMT1 by HCVc mediated the suppression of
miR-124. Over-expression of miR-124 suppressed cell migration and invasion in vitro, and reduced
the protein levels of SMYD3 and downstream target genes (c-Myc and MMP9). Knockdown of SMYD3
inhibited cell migration and invasion resembling that of miR-124 over-expression. In conclusion,
our studies indicate that low miR-124 levels mediated by HCVc via DNMT1 promote ICC cell migra-
tion and invasion by targeting SMYD3.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.01. Introduction
Intrahepatic cholangiocarcinoma (ICC), derived from cholangio-
cytes of small intrahepatic bile ducts or bile ductules, is the second
most common primary liver cancer [1]. Prognosis of ICC remains
very poor due to its late clinical presentation, lack of effective
non-operative therapy, and rapid turnover.
Chronic hepatitis C virus infection results in liver injury and
long-term complications such as cirrhosis and cholangiocarcinoma
[2,3]. Hepatitis C Virus core protein (HCVc) is a structural protein
encoded by the most conservative region of HCV genome, and
has been strongly implicated in ICC pathogenesis due to its role
in transcriptional regulation of cellular gene expression through
its interaction with cytoplasmic proteins and signal transduction
pathways [4].
MicroRNAs (miRNAs), a class of small non-coding RNAs, that
regulate gene expression by binding to the 30-untranslated regionschemical Societies. Published by E
ma; HCVc, Hepatitis C Virus
3, SET and MYND domain-
Chen), fax: +86 20 81332107
enrf63@163.com (R. Chen).(3 -UTRs) of target mRNAs to cause mRNA degradation and/or pro-
tein translation inhibition [5]. Deregulation of miRNAs has been
observed in various tumors, including ICC [6]. Previous proﬁle
studies of miRNAs expression have documented a dysregulation
of a series of miRNAs, including miR-124, in HCV-related liver can-
cer [7]. MiR-124, a highly expressed miRNA in the central nervous
system, has been reported to regulate a plethora of target proteins,
which are involved in cell cycle, differentiation, cellular develop-
ment and migration [8–11]. Additionally, miR-124 has also been
found epigenetically silenced in breast, colon, gastric and hemato-
poietic malignancies [12–14]. To date, however, the regulation of
miR-124 in HCV-ICC and the mechanisms by which miR-124 exerts
its functions remain largely unknown.
In this study, we elucidate a general reduction of miR-124 level
in HCV-ICC, and the induction of DNA methyltransferase 1
(DNMT1) mediated the suppression of miR-124 in HCVc-express-
ing ICC cells. Next, we conﬁrmed that the histone methyltransfer-
ase SET and MYND domain-containing protein 3 (SMYD3) was a
direct target of miR-124, and involved in miR-124-induced sup-
pression of cell migration and invasion. Our results cast a new light
on the functions of miR-124 as both genetic and epigenetic regula-
tors in the pathogenesis of HCV-ICC.lsevier B.V. All rights reserved.
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2.1. Cell culture
The human intrahepatic cholangiocarcinoma cell lines, RBE and
HCCC-9810 (purchased from Chinese Academy of Sciences Cell
Bank of Type Culture Collection, Shanghai, China), were maintained
in RPMI-1640 supplemented with 10% fetal bovine serum. HCVc-
expressing ICC cells (RBE-core/HCCC-9810-core) were cultured in
RPMI-1640 supplemented with 10% FBS and 200 lg/mL G418. All
cell lines were maintained at 37 C in a humidiﬁed atmosphere
with 5% CO2.
2.2. Patient tissue samples
Samples were obtained from patients who underwent radical
resection at the Sun Yat-sen Memorial Hospital and the First Afﬁl-
iated Hospital of Sun Yat-sen University. Twenty-ﬁve samples were
used for this study, including 10 primary ICC samples, 10 HCV-ICC
samples, and 5 HCV-HCC (hepatocellular carcinoma) samples. In-
formed consent was obtained from all patients.
The study was approved by the Institute Research Ethics Com-
mittee at the Sun Yat-sen University.
2.3. RNA oligoribonucleotides and plasmids
MiR-124 mimics and negative control (NC) were purchased
from RiboBio (Guangzhou, China). SMYD3 and DNMT1 speciﬁc siR-
NA, and negative control (NC) were purchased from GenePharma
(Shanghai, China). To construct the HCVc-expressing plasmid pEG-
FP-C3-Core, the full-length HCV Core sequence (genotype1b) was
cloned into pEGFP-C3. To create luciferase reporter construct, a
wild-type 30-UTR fragment of human SMYD3 mRNA that contained
putative binding sites for miR-124 was PCR-ampliﬁed and cloned
downstream of the luciferase reporter gene of a pGL3 vector. The
mutant 30-UTR, which carried the mutated sequence in the com-
plementary site for the seed region of miR-124, was generated
using fusion PCR based on the construct with wild-type 30-UTR.
Primers used for PCR are provided in Supplementary Table S1. pEG-
FP-SMYD3 plasmid was constructed as previously described [15].
2.4. Cell transfection
RNA oligoribonucleotides and plasmids were transfected using
Lipofectamine™ RNAiMAX or Lipofectamine2000 (Invitrogen),
according to the manufacturer’s instructions. For stable transfec-
tion, RBE and HCCC-9810 cells were exposed to 200 lg/mL G418
24 h after transfection with pEGFP-C3-Core or pEGFP-C3. G418-
resistant cells were further cultured to select the monoclones.
2.5. Reverse-transcription PCR, quantitative real-time PCR and
Methylation speciﬁc PCR (MSP)
Total RNA from tissue samples and cultured cells was extracted
using TRIzol reagent (Invitrogen). The reverse-transcription PCR
(RT-PCR) was performed using transcriptase (Invitrogen), and the
quantitative real-time PCR (qRT-PCR) was performed in a Light-
Cycler480 System using a SYBR Premix ExTaq kit (Takara Biotech-
nology, Dalian, China) according to the manufacturer’s
instructions. The sequences of the qRT-PCR primers are listed in
Supplementary Table S1. The expression level of mature miR-124
was detected using the Hairpin-it miRNAs qRT-PCR Quantitation
assay (RiboBio, Guangzhou, China) according to the provided pro-
tocol, and U6 small nuclear RNA was used as an endogenous con-
trol. Each assay was carried out in triplicate.The DNA methylation status was established by PCR analysis of
bisulﬁte-modiﬁed genomic DNA, which induces chemical conver-
sion of unmethylated, but not methylated, cytosine to uracil, using
two procedures. Methylation status was analyzed by MSP using
primers speciﬁc for either the methylated or modiﬁed unmethylat-
ed DNA as previously described [13]. The primers used are de-
scribed in Supplementary Table S1.
2.6. Western blot analysis
Cell cytosolic protein fractions were prepared using RIPA buffer
(Beyotime Biotechnology). According to standard Western blot
procedures, brieﬂy, proteins were separated by SDS–PAGE and
then transferred to PVDF membranes. After blocking in 5% nonfat
milk, the membranes were incubated with the following primary
antibodies: HCVc antibody (Santa Cruz Biotechnology), DNMT1,
DNMT3A and DNMT3B antibody (Abcam), SMYD3 antibody
(Cambridge), c-Myc, MMP9 and GAPDH antibody (Cell Signaling
Technology), and b-Actin antibody (Boster), according to the man-
ufacturer’s instructions.
2.7. Cell migration and invasion assays
Cell motility was assessed using a wound healing assay. Brieﬂy,
cells were seeded in 6-well plates the day before transfection. After
24 h, transfected cells were wounded by a 20 ll sterile pipette tip,
and washed using PBS to remove cellular debris and allowed to mi-
grate for 24 h. Wound closure or cell migration images were pho-
tographed using an inverted microscope. Results were expressed as
a migration index—that is, the distance migrated by miR-124 trea-
ted (or targeted) relative to the distance migrated by control RNA
treated (or Blank) cells. Experiments were carried out in triplicate
and repeated at least three times.
Cell invasion assays were performed using 24-well transwells
(8-lm pore size, BD Sciences) coated with matrigel (1 mg/ml, BD
Sciences). Brieﬂy, 24 h after transfection, cells were collected and
resuspended in 100 ll of RPMI-1640 medium without serum,
and transferred into the upper chamber precoated with matrigel.
RPMI-1640 medium containing 10% FBS in the lower chamber
served as chemoattractant. After several hours of incubation, the
cells that did not invade through the pores were carefully removed
using a cotton swab. Then the inserts were stained with 0.2% crys-
tal violet, imaged, and counted under an inverted microscope in six
randomly selected ﬁelds. Experiments were carried out in tripli-
cate and repeated at least three times.
2.8. Luciferase reporter assay
RBE-core cells were seeded in 48-well plates the day before
transfection. Cells were ﬁrst transfected with 100 nM NC or
miR-124 mimics. Twenty-four hours later, the RNA-transfected
cells were co-transfected with 50 ng of ﬁreﬂy luciferase reporter
containing wild-type or mutant 30-UTR of target gene and 20 ng
of Renilla vector (pRL-TK). Forty-eight hours later, Fireﬂy and
Renilla luciferase activities were measured with a Dual-Luciferase
Reporter Assay System (Promega). Luciferase activity was normal-
ized for transfection efﬁciency using the corresponding Renilla
luciferase activity. All experiments were performed at least three
times.
2.9. Statistical analysis
Data are presented as mean ± standard deviation (SD). The Stu-
dent’s t-test was used for statistical analysis, and P values of less
than 0.05 were regarded as statistically signiﬁcant.
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3.1. miR-124 is down-regulated in HCV-related ICC
Because miR-124 has been reported to have multiple roles in
tumor suppression, and was down-regulated in different types of
cancer [16–18], we were therefore led to ask whether miR-124
was down-regulated in HCV-ICC. Compared with the adjacent non-
tumor tissues, miR-124 was signiﬁcantly down-regulated by
approximately four-fold among the HCV-ICC samples. Very slight
down-regulation of miR-124 was shown in HCV-negative ICC
(Fig. 1A). Interesting, a similar down-regulation of miR-124 was
also found in HCV-HCC (Fig. S1A) and the adjacent normal liver tis-
sues of HCV-ICC also shown a lower expression level of miR-124,
but have no statistically signiﬁcant (Fig. S1B).
Recent study that HCV proteins exert a profound impact on the
cellular miRNAs expression [19], prompted us to ask whether this
down-regulation correlated with HCVc expression. In order to ver-
ify this hypothesis, HCVc-expressing plasmid or empty vector were
transfected into the RBE and HCCC-9810 cells, and then performed
G418 selection. Clones were screened for HCVc mRNA and protein
expression (Fig. 1B and C). Compared with control group, the
expression level of miR-124 was signiﬁcantly decreased in HCVc-
expressing ICC cells (Fig. 1D).
3.2. DNMT1 is responsible for the HCVc-mediated miR-124 repression
Given that miR-124 has been reported epigenetically regulated
in various tumors [13,14,20], we explored the possibility whetherFig. 1. miR-124 is down-regulated in HCV-ICC. (A) Relative expression of miR-124 in HC
Western blot analysis conﬁrmed the mRNA and protein expression of the HCVc gene in
cells that stably expressed HCVc or control vector was determined by qRT-PCR. All dataHCVc represses miR-124 expression via epigenetic pathways. To
prove this hypothesis, we ﬁrst examined if the reduced expression
of miR-124 could be restored upon treatment with a DNA methyl-
ation inhibitor, 5-Aza-dC. Interestingly, miR-124 expression in
HCVc-expressing ICC cells increased signiﬁcantly following treat-
ment with 5-Aza-dC compared with controls (Fig. 2A). As a positive
control, p16 expression levels were also increased on treatment
with 5-Aza-dC (Fig. S2A). In addition, MSP analysis shown that
the frequency of 5-methylcytosine markedly increased in the pres-
ence of HCVc (Fig. 2B, lanes 1 and 2), and treatment with 5-Aza-dC
abolished the effects of HCVc on the DNA methylation (Fig. 2B,
lanes 3 and 4). These results suggest that epigenetic modiﬁcation
of regulatory sequences in CpG islands by HCVc may contribute
to miR-124 repression in ICC cells.
Epigenetic regulation of gene has been associated with DNA
methyltransferase, and it has been reported that HCVc can regulate
gene expression via DNMT1 and DNMT3B [21,22]. Thus, we next
explored whether DNMTs were responsible for the HCVc-mediated
miR-124 repression. As shown in Fig. 2C, DNMT1 was signiﬁcantly
up-regulated by HCVc, while the levels of DNMT3A and DNMT3B
were not signiﬁcantly changed. To determine whether DNMT1 is
responsible for the HCVc-mediated miR-124 repression in ICC cells,
we conducted RNA interference experiments using siRNA speciﬁc
for DNMT1 (Fig. 2D). Interestingly, the expression levels of miR-
124 signiﬁcantly increased when DNMT1 was knocked-down
(Fig. 2E). And the effect of HCVc on the methylation of miR-124
gene was almost completely abolished (Fig. 2F). Moreover, the
expression levels of DNMT1 in HCV-ICC samples were up-regulated
and negatively correlated with miR-124 expression (Fig. S2C).V-ICC samples or HCV negative ICC was determined by qRT-PCR. (B) RT-PCR and (C)
RBE-core and HCCC-9810-core cell lines. (D) Relative expression of miR-124 in ICC
are shown as the mean ± SD based on three independent experiments. ⁄⁄P < 0.01.
Fig. 2. DNMT1 is responsible for the HCVc-mediated miR-124 repression. (A) Expression levels of miR-124 in HCVc-expressing ICC cells were up-regulated upon 5-Aza-dC
treatment in a dose-dependent manner. (B) Genomic DNA was puriﬁed from RBE-VC (lanes 1 and 3) and RBE-core cells (lanes 2 and 4) after either mock treated (lanes 1 and
2) or treated with 5-Aza-dC (lanes 3 and 4) for 24 h. MSP analysis was performed to determine whether CpG island of the miR-124 gene promoter is either methylated (M) or
unmethylated (U). (C) Protein and mRNA levels of DNMT1 in ICC cells were determined by Western blot and qRT-PCR. (D) NC or si-DNMT1 was introduced into HCVc-
expressing ICC cells, protein levels of DNMT1 were detected byWestern blot. (E) NC or si-DNMT1 was introduced into HCVc-expressing ICC cells, expression levels of miR-124
were determined by qRT-PCR. (F) NC (lane 3) or si-DNMT1 (lane 4) was introduced into RBE-core cells. MSP analysis was performed to determine the methylation status of
miR-124 gene promoter. All data are shown as the mean ± SD based on three independent experiments. ⁄P < 0.05, ⁄⁄P < 0.01.
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3.3. Restoration of miR-124 inhibits tumor cell migration and invasion
in vitro
Although the tumor-suppressive capacity of the miR-124 has
been well documented in other cancers, the role of it in HCV-
ICC is largely unknown. Firstly, clone formation and MTT assays
were performed to evaluate the effect of miR-124 on proliferation
of HCVc-expressing ICC cells. Our results showed that miR-124had no obvious effect on cell proliferation (Fig. S3A, B and C).
Next, to analyze the effect of miR-124 on cell migration and inva-
sion, miR-124 mimics was transfected into RBE-core and HCCC-
9810-core cells, respectively. Wound-healing assays showed that
ectopic expression of miR-124 caused a suppression of cell migra-
tion in RBE-core and ICC-9810-core cells (Fig. 3A and B). Matrigel
invasion assays demonstrated that over-expression of miR-124
markedly reduced invasiveness of RBE-core and ICC-9810-core
cells (Fig. 3C and D). Taken together, our results suggest that
miR-124 is a negative regulator for migration and invasion of
ICC cells.
Fig. 3. Ectopically expressed miR-124 represses cell migration and invasion in vitro. (A and B) Wound healing assays were performed on HCVc-expressing ICC cells
transfected with either miR-124 mimics or NC. One representative experiment is shown. (C and D) Matrigel invasion assays showed that the cell invasion was signiﬁcantly
inhibited by miR-124 in HCVc-expressing ICC cells. A histogram shows the relative cell number of six randomly selected ﬁelds. All data are shown as the mean ± SD based on
three independent experiments. ⁄⁄P < 0.01.
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sition (EMT). To address whether or not miR-124 mediated inva-
sion was associated with EMT, HCVc-expressing ICC cells were
photographed before and after transfection. However, we did not
observed morphological changing with miR-124 mimics transfec-
tion (Fig. S3D). Our results suggest that miR-124mediated invasion
of HCVc-expressing ICC cells may not associate with EMT.3.4. miR-124 directly targets SMYD3 30-UTR
It is well documented that miRNAs exert their function by reg-
ulating target genes expression [23]. To explore the mechanism of
miR-124 mediated migration and invasion, we used TargetScan
algorithm to search for putative protein-coding gene targets of
miR-124. Our analysis revealed that SMYD3 was a potential target
3276 B. Zeng et al. / FEBS Letters 586 (2012) 3271–3278of miR-124. To validate whether SMYD3 is a direct target of miR-
124, the full length 3’-UTR fragments of SMYD3 and corresponding
mutant counterpart were directly cloned to the downstream of the
ﬁreﬂy luciferase gene (Fig. 4A). As shown in Fig. 4B, miR-124 signif-
icantly suppressed the ﬁreﬂy luciferase activity of the reporter
with wild-type 30-UTR but not that of the mutant reporter. More-
over, ectopic expression of miR-124 could reduce the protein levels
of SMYD3 without changing the mRNA levels (Fig. 4C and D). Addi-
tionally, we found that the expression levels of c-Myc and MMP9,
downstream target genes of SMYD3, were also down-regulated
upon over-expression of miR-124 (Fig. 4C). Taken together, these
results suggest that miR-124 may inhibit the expression of SMYD3
at posttranscriptional level by directly targeting the 30-UTR of
SMYD3 mRNA.
3.5. SMYD3 is involved in the cell migration and invasion mediated by
miR-124
It has been reported that SMYD3 is closely related to tumor
migration and invasion [24,25]. However, the effects of SMYD3
on cholangiocarcinoma cells have not been characterized. To eval-
uate whether or not SMYD3 is involved in miR-124 mediated
migration and invasion, we knockdown of SMYD3 by siRNA
(Fig. 5A). We found that si-SMYD3 could inhibit cell migration
and invasion (Fig. 5B and C), which resembled the inhibitory effects
of miR-124. Next, we co-transfected HCVc-expressing ICC cells
with miR-124 mimics and pEGFP-SMYD3 plasmid as described in
Fig. 5D, the expression of SMYD3 was conﬁrmed by Western
blotting. Interestingly, we found that the migration and invasion
suppressing effects of miR-124 were partially attenuated by
over-expression of SMYD3 (Fig. 5E and F), suggesting SMYD3 is in-
volved in miR-124-induced suppression of migration and invasion
of HCVc-expressing ICC cells.Fig. 4. SMYD3 was negatively regulated by miR-124. (A) Schematic depiction of a miR-12
luciferase activity. RBE-core cells were ﬁrst transfected with 100 nM NC or miR-124 mim
luciferase reporter plasmid containing either wild-type or mutant SMYD3 30-UTR and pRL
shown as the relative ﬁreﬂy activity normalized as to renilla one. The assay was performe
in miR-124-transfected cells were determined by Western blot. GAPDH served as a loadin
by qRT-PCR. All data are shown as the mean ± SD based on three independent experime4. Discussion
Recently, several viruses, including HCV, have been conﬁrmed
to interact with cellular miRNAs in viral pathogenesis [26,27]. Such
as miR-122, the liver-speciﬁc cellular miRNAs, facilitates the repli-
cation of HCV by targeting the viral 50 non-coding region [28].
While other miRNAs that induced by HCV (miR-29, miR-196,
miR-199a and miR-491) can reduce HCV abundance in culture
[29–32]. In addition, HCV proteins can also alter host miRNAs
expression. Up-regulation of miR-193b induced by HCV proteins
facilitates chemo-sensitivity to sorafenib in malignant hepatocytes
[19]. Despite of increasing knowledge about miRNAs in HCV infec-
tion and associated pathological processes, mechanisms by which
HCV modulates miRNAs expression and the role of miRNAs in
HCV-ICC are largely unknown.
In this study, we observed that miR-124 was frequently down-
regulated in HCV-ICC, and over-expression of miR-124 could sup-
press cell migration and invasion of HCVc-expressing ICC cells,
suggesting that low expression levels of miR-124 is associated with
cholangiocarcinoma progression. Further studies showed that this
depression of miR-124 in cholangiocarcinoma correlated with
HCVc expression. Moreover, treatment of 5-AZA-dC restored the
expression of miR-124 in a dose depend manner, suggesting that
HCVc may modulate miR-124 expression via epigenetic
modiﬁcation.
It is widely accepted that miRNAs undergo the same regulatory
mechanisms of the protein-coding gene, including epigenetic reg-
ulation. DNMT1, DNMT3A and DNMT3B are the enzymes responsi-
ble for setting up and maintaining DNA methylation patterns in
eukaryotic cells [33]. Lujambio [13] found that a double knockout
(DKO) for DNMT1 and DNMT3B re-expression a number of miRNAs
in colorectal cancer cell line, including miR-124. Dickstein [34]
reported that miR-1 is frequently silenced by promoter4 seed match in the 3’-UTR of SMYD3 mRNA and its point mutations. (B) Analysis of
ics. Twenty-four hours later, the transfected cells were co-transfected with ﬁreﬂy
-TK. Luciferase activity was determined by means of the dual luciferase assay and is
d in three independent experiments. (C) Protein levels of SMYD3, c-Myc and MMP9,
g control. (D) mRNA levels of SMYD3 in miR-124-transfected cells were determined
nts. ⁄⁄P < 0.01.
Fig. 5. SMYD3 is involved in the cell migration and invasion mediated by miR-124. (A) Silencing of SMYD3 was conﬁrmed by Western blot in HCVc-expressing ICC cells after
transfection of speciﬁc si-SMYD3. (B and C) Knockdown of SMYD3 expression inhibits migration and invasion of HCVc-expressing ICC cells. (D) After transfection of miR-124
mimics, pEGFP-SMYD3, or NC, protein levels of SMYD3 in HCVc-expressing ICC cells were determined by Western blot. (E and F) HCVc-expressing ICC cells after transfection
of miR-124 mimics, pEGFP-SMYD3, or NC were subjected to migration and invasion assays.
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not DNMT3B, rescued the expression of miR-1–1 in HCT-116 cells
[34]. In this study, we revealed that DNMT1 was signiﬁcantly up-
regulated by HCVc, and knockdown of DNMT1 could lead to miR-
124 restoration, suggesting the induction of DNMT1 is responsible
for the down-regulation of miR-124 in HCVc-expressing ICC cells.
Recently, Park [21] reported that HCVc can regulate p16 expression
via up-regulation of DNMT1 and DNMT3B in HepG2 cells.
However, we did not found the up-regulation of DNMT3B in
HCVc-expressing ICC cells. This may be partially explained by
multifactorial etiology of cancer.
The relationship between miRNAs and epigenetic effectors is of
great interest given that a subgroup of epigenetically silenced miR-
NAs can also regulate the expression of epigenetic effectors, suchas DNMTs, HDACs, and polycomb genes. MiR-29 family was ﬁrst
conﬁrmed to directly target DNMT3A and DNMT3B in lung cancer
cell lines [35]. MiR-148a, another epigenetically regulated miR-
NA[12,36], was also found to directly target DNMT3B [37]. Re-
cently, Zheng [10] reported that the putative tumor suppressor
miR-124 can modulate hepatocellular carcinoma cell aggressive-
ness by repressing the polycomb gene EZH2. Interesting, miR-124
was also epigenetically regulated in different types of cancer
[12–14,38,39]. In the present study, we identiﬁed another direct
target of miR-124: SMYD3, an important histone methyltransfer-
ase involved in tumor progression. Importantly, we found that
knockdown of SMYD3 largely mimicked the migration and inva-
sion effect of miR-124 over-expression, suggesting that SMYD3 is
a pivotal mediator of miR-124-inhibited invasiveness in
3278 B. Zeng et al. / FEBS Letters 586 (2012) 3271–3278HCVc-expressing ICC cells. In consistent with previous studies, our
data suggest that epigenetically regulated miRNAs can also control
the expression of epigenetic effectors, and may exert a profound
impact on tumor progression.
Matrix metalloproteinase (MMP) proteins play critical functions
in cancer progression. Recently, Cock-Rada [25] reported that
SMYD3 promotes cancer invasion by epigenetic up-regulation of
MMP-9. To demonstrate the role of miR-124 in regulation of
SMYD3, we further examined the effect of miR-124 on c-Myc and
MMP9, downstream target genes of SMYD3. Interestingly, our data
showed that over-expression of miR-124 was able to depress
c-Myc and MMP9 expression, supporting that miR-124 regulates
SMYD3. Clearly, our data, together with the other ﬁndings, demon-
strate that miR-124 plays a pivotal role in tumor migration and
invasion by targeting multiple proteins.
Taken together, our present work indicates that low miR-124
levels induced by HCVc via DNMT1 promote ICC cell migration
and invasion by targeting SMYD3, and miR-124 could be employed
as an effective therapeutic target for HCV-ICC. Our studies cast a
new light on the functions of miR-124 as both genetic and epige-
netic regulators in the pathogenesis of HCV-ICC. Although our re-
sults support the hypothesis that HCVc down-regulates miR-124
expression by epigenetic modiﬁcation, the expression of miR-124
might be regulated by other mechanisms.
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